2024 annual financial data
Cumberland Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -1.62%.
Operating income was -6,432,409 USD and net income was -6,479,770 USD.
Operating cash flow was -612,186 USD.
Get free Cumberland Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,867,945 USD
- Operating income
- -6,432,409 USD
- Net income
- -6,479,770 USD
- Operating cash flow
- -612,186 USD